During a Case-Based Roundtable® event, Evan J. Lipson, MD, moderated a discussion on the tolerability of immunotherapy in metastatic melanoma and when to stop therapy.
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
Stanford scientists have identified 380 key genetic variants that significantly influence cancer development, filtering ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...
StarsInsider on MSN22h
Everything you need to know about lung cancerLung cancer is one of the most common, most dangerous, and most frequently talked about forms of cancer in the world. Of all ...
POTOMAC, MARYLAND / ACCESS Newswire / February 18, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") today announced its financial results for the third fiscal quarter of 2025 ended December 31, ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback